Hemay Pharmaceutical, founded in 2002, is a pharmaceutical enterprise dedicated to the independent research and development (R&D) and industrialization of global innovative drugs. Guided by unmet clinical needs in its R&D efforts, the company adheres to the development objective of "rooting in China and targeting the global market" and proactively carries out global layout in terms of projects, patents, and industrial chains. It has established multiple subsidiaries, covering all functional segments from R&D to production.
Overcome the bottlenecks inherent in classical paradigms and create exceptional clinical value.
Hemay has consistently upheld its mission of "developing more effective, safer, and more cost-efficient novel drugs for patients" and adhered to the principle of "being accountable to patients". Through interdisciplinary collaboration and scientific innovation, the company is actively striving to build a world-class research, development, and manufacturing hub for value-driven pharmaceuticals.
In its R&D endeavors, Hemay avoids unreflective pursuit of emerging targets or trending research areas. Instead, it persists in leveraging its proprietary R&D platforms and core technologies as the foundation, focusing on creating products with exceptional clinical value. The company’s R&D pipeline spans therapeutic areas including autoimmune diseases and oncology, with multiple indications already in the NDA (New Drug Application) stage or pivotal clinical trial phase.
Hemay’s projects have repeatedly garnered recognition and support from government agencies at all levels and research institutions. To date, Hemay has independently undertaken three projects under the National Science and Technology Major Project of "Major New Drug Innovation".
Hemay adheres to an "open and grateful" mindset, actively seeking opportunities for win-win cooperation, and has gained wide recognition and support from all sectors. Hemay has not only established long-term strategic partnerships with many pharmaceutical enterprises (institutions), but also carried out multiple fruitful research and development collaborations with renowned universities. As the projects and the company develop, the company's value has been further recognized by the market and capital. Hemay has received multiple rounds of investment from many top venture funds and investors. Hemay looks forward to working with you to achieve the ideal and goal of "enabling the world to use good drugs developed by the Chinese".
